Temporal and spatial relationship between no-reflow phenomenon and postischemic necrosis in skeletal muscle

被引:20
|
作者
Hickey, MJ
Hurley, JV
Morrison, WA
机构
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1996年 / 271卷 / 04期
关键词
reperfusion injury; ischemia; microcirculation;
D O I
10.1152/ajpheart.1996.271.4.H1277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of these experiments was to describe clearly the spatial relationship between the no-reflow phenomenon and tissue injury in postischemic skeletal muscle. Using the rectus femoris muscle of anesthetized rabbits, we examined microvascular perfusion in untreated muscles and in muscles after 3.5 h of ischemia and 10 min, 1 h, and 24 h of reperfusion. Microvascular perfusion was assessed by infusion of biological ink and quantitation of 1) the area of capillary filling in histological sections, and 2) the ratio of perfused capillaries to muscle fibers in perfused areas (C/F). After 10 min of reperfusion, perfused cross-sectional area had decreased from 67.0 +/- 20.0 to 10.6 +/- 5.6 (SD)%, and C/F was also significantly reduced. These changes persisted for at least 24 h. After 10 min of reperfusion, flow was randomly distributed throughout the muscle. However, after 24 h, perfusion was confined to the peripheral tissue in areas that were also viable as demonstrated by nitro blue tetrazolium staining. These results show that in this model, in the early stages of reperfusion, flow is established in some areas, which are destined to become necrotic.
引用
收藏
页码:H1277 / H1286
页数:10
相关论文
共 50 条
  • [21] EFFECT OF EXOGENOUS ADENOSINE (ADO) ON NO-REFLOW PHENOMENA IN SKELETAL-MUSCLE
    COLGIN, SL
    PROCTOR, KG
    FASEB JOURNAL, 1988, 2 (04): : A945 - A945
  • [22] EFFECT OF TOPICAL ADENOSINE (ADO) ON NO-REFLOW IN ISCHEMIC SKELETAL-MUSCLE
    COLGIN, SL
    HICKERSON, WL
    PROCTOR, KG
    SOUTHERN MEDICAL JOURNAL, 1988, 81 (09) : S72 - S72
  • [23] Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction
    Iwakura, K
    Ito, H
    Ikushima, M
    Kawano, S
    Okamura, A
    Asano, K
    Kuroda, T
    Tanaka, K
    Masuyama, T
    Hori, M
    Fujii, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (01) : 1 - 7
  • [24] REASSESSMENT OF CEREBRAL CAPILLARY CHANGES IN ACUTE GLOBAL ISCHEMIA AND THEIR RELATIONSHIP TO NO-REFLOW PHENOMENON
    FISCHER, EG
    AMES, A
    HEDLEYWHYTE, ET
    OGORMAN, S
    STROKE, 1977, 8 (01) : 36 - 39
  • [25] Relationship Between Systemic Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction
    Celik, Muhammet Cihat
    Karayigit, Orhan
    Ozkan, Can
    Dolu, Abdullah Kadir
    Kalcik, Macit
    ANGIOLOGY, 2023, 74 (04) : 387 - 394
  • [26] The Relationship Between High-Dose Atorvastatin Loading and the No-Reflow Phenomenon in STEMI Patients Undergoing Primary PCI
    Hennawy, Bassam S.
    Mohammed, Amr M.
    Fouad, Khaled A.
    IRANIAN HEART JOURNAL, 2025, 26 (01): : 54 - 66
  • [27] The Association Between Atherogenic Index of Plasma and No-Reflow Phenomenon in Acute Coronary Syndrome
    Celik, Ibrahim Etem
    Ozturk, Selcuk
    Yarlioglu, Mikail
    Barutcu, Ozan
    Akgun, Onur
    Duran, Mustafa
    Yorulmaz, Sukru
    Murat, Sani Namik
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (12): : 712 - 719
  • [28] Postischemic flap washout with hydroxyethyl starch (HAES) and its beneficial effect on the no-reflow phenomenon in rat skin island flaps
    Akın S.
    Özcan M.
    European Journal of Plastic Surgery, 1998, 21 (5) : 238 - 242
  • [29] Postischemic flap washout with hydroxyethyl starch (HAES) and its beneficial effect on the no-reflow phenomenon in rat skin island flaps
    Akin, S
    Ozcan, M
    EUROPEAN JOURNAL OF PLASTIC SURGERY, 1998, 21 (05) : 238 - 242
  • [30] Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention
    Su, Qiang
    Ye, Ziliang
    Sun, Yuhan
    Yang, Huafeng
    Li, Lang
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (04): : 318 - 324